Imperial Recognized as 2026 National Best and Brightest Company to Work For! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Category:

Clinical Trial Business Insights

    Writing Clinical Trial Content by Committee: Getting Everyone on the Same Page
    Clinical Trial Business InsightsClinical Trial Materials Development and Printing

    Writing Clinical Trial Content by Committee: Getting Everyone on the Same Page

    by Erica Manning May 31, 2018
    written by Erica Manning

    The more the merrier? Sure, there are many times when that holds true, but not when it comes to having multiple players contribute to writing clinical trial content. Do you sometimes feel like your documents are constantly stuck in the review process?

    You are likely stumbling across common pitfalls. To keep your projects moving forward, take these simple steps:

    Get stakeholders involved early.

    Nobody enjoys being surprised by content that negatively affects their part of a project. Ask yourself who will use the documents and for what purpose. Then be sure to confirm who needs to approve the documents before they are final. You will want to create a plan that includes a sufficient turnaround time for each approving body. You can then determine if any groups can review content simultaneously, why they need to approve the documents, and what parameters they may have on the types of changes they can make. Giving stakeholders notice also helps give you a chance to address concerns well in advance.

    Who can make what changes to the clinical trial content?

    The most painful and time-consuming part of navigating clinical trial content approvals is unnecessary additional rounds of revisions. To avoid this, evaluate each approving body’s area of expertise. Then, when you send a document for review, be sure to include acceptable types of changes or specific parameters along with your deadline.

    Who is the leader?

    When approving bodies disagree, who wins? By identifying areas of expertise, you can avoid a direct conflict over a particular piece of text. It helps to identify early on individuals to escalate to within an organization. This can be tricky when teams do not report to a common person. Another smart technique is to specify a clear document owner that has the authority to make final decisions. If the approval process in your organization does not allow you any of these options, you should consider a process improvement initiative, as it could be costing your organization money in wasted time and labor.

    A little project planning around your document approval process can save you time, money, and anxiety. Contact us if you need help.

    Some of our other clinical trial writing blogs, https://www.imperialcrs.com/blog/2021/06/24/writing-clinical-trial-materials-3-steps-to-simplify-language-increase-readability/, https://www.imperialcrs.com/blog/2018/08/26/clinical-study-content-meets-clinical-trial-design-bringing-project-life/.

    Updated: 14 August 2022

    May 31, 2018 0 comments
    0 FacebookTwitterLinkedinEmail
  • Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business InsightsParticipant Engagement

    Bridging Research and Health Care: If We Don’t Do it, Someone Else Will

    by Dan McDonald May 21, 2018
    by Dan McDonald May 21, 2018

    I recently had the honor and privilege of representing Imperial at the inaugural Bridging Clinical Research and Clinical Health Care conference in National Harbor, Maryland. It was interesting and worthwhile. The conference brought together heavy hitters and important voices, including the FDA and advocates from …

    0 FacebookTwitterLinkedinEmail
  • Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business Insights

    Pre-approval communications prior to export: Why are they so important?

    by Dan Polkowski May 3, 2018
    by Dan Polkowski May 3, 2018

    The best way to answer this question is with the catchphrase a chain is only as strong as its weakest link.  After 25 years of managing global clinical trial studies for clients, I cannot emphasize enough how much this phrase relates to the global distribution …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    Patient Centricity: Tools to Apply To Clinical Trials

    by Melynda Geurts April 18, 2018
    by Melynda Geurts April 18, 2018

    If you’re a professional in the clinical trial world, you have probably heard about patient centricity. It has been a top industry buzzword for the last few years. But patient centricity is more than just a buzzword. So much more. It’s being put to use in …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Surviving the Transition Into Clinical Trials: Getting Started

    by Hope Cullen April 5, 2018
    by Hope Cullen April 5, 2018

    We recently held the second of our presentation series “Surviving the Transition to Clinical Trials” at JLABS in Toronto. More than 45 people, representing biotech, pharma, and medical device companies, came to find out how to take their innovative ideas from the lab to the …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    A look at – Outsourcing in Clinical Trials West Coast Conference

    by Kristin Gross March 15, 2018
    by Kristin Gross March 15, 2018

    The 10th Annual Outsourcing in Clinical Trials West Coast Conference covered a wide range of subjects. New this year were three tracks on clinical innovation, early phase development, and data-driven approaches, and attendees heard the latest on artificial intelligence and blockchain technology. Whiteboard sessions, panel …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    SCOPE Summit 2018: Excitement and Engagement

    by Dave Woodard February 28, 2018
    by Dave Woodard February 28, 2018

    I had the opportunity to attend the SCOPE Summit for Clinical Ops Executives in Orlando, February 12-15. It’s been a few years since I last attended a SCOPE Summit, so it was interesting to see that some clinical research issues have evolved, while others persist …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    3 Ways to Outsmart the Big Dogs as You Move into the Clinic

    by Dan McDonald February 23, 2018
    by Dan McDonald February 23, 2018

    You’ve done all the background work. You’ve navigated the complex U.S. regulatory environment and achieved investigational new drug approval. You’ve secured investors and assembled your core team. You are now preparing for the next big milestone for your burgeoning biopharmaceutical company – entering the clinic. …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business InsightsParticipant Engagement

    The Role of Patient Engagement in the Transition from Lab to Clinic

    by Dan McDonald January 17, 2018
    by Dan McDonald January 17, 2018

    The drug discovery and development process is a complex and challenging landscape, especially for the majority of small biopharmaceutical and medical device companies. It’s truly a survival of the fittest environment, fraught with potential pitfalls and company killers. For every Kite Pharma (acquired by Gilead …

    0 FacebookTwitterLinkedinEmail
  • Clinical Trial Business Insights

    Looking Ahead

    by Steve Swanson January 9, 2018
    by Steve Swanson January 9, 2018

    Each year I take time to put forth my observations about the year ahead. From a geopolitical perspective, I will not enter the fray, except to say as business leaders, the need exists to navigate a variety of waters. One positive event is the improving …

    0 FacebookTwitterLinkedinEmail
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email Rss

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Clinical Trial Supplies and Equipment (44)
  • Clinical Trial Business Insights (198)
  • Clinical Trial Materials Development and Printing (55)
  • Participant Engagement (113)
  • Translation of Clinical Trial Materials (21)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribetoourblogandgetthelatestupdates,insights,andindustrytrendsdeliveredstraighttoyourinbox.Stayinformedandnevermissapost.

 

 


Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace